Persones / Equip Humà

Marçal Pastor-Anglada

Buscador de publicacions

Publicacions

  • Govindarajan R, Endres CJ, Whittington D, LeCluyse E, Pastor-Anglada M, Tse CM and Unadkat JD.

    Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytes.

    AM J PHYSIOL-GASTR L . 295(3): . Nº de cites: 59

    [doi:10.1152/ajpgi.00542.2007]

  • Perez-Torras S, García-Manteiga J, Mercadé E, Casado FJ, Carbó N, Pastor-Anglada M and Mazo A.

    Adenoviral-mediated overexpression of human equilibrative nucleoside transporter 1 (hENT1) enhances gemcitabine response in human pancreatic cancer.

    BIOCHEMICAL PHARMACOLOGY . 76(3): 322-329. Nº de cites: 42

    [doi:10.1016/j.bcp.2008.05.011]

  • Pastor-Anglada M, Cano-Soldado P, Errasti-Murugarren E and Casado FJ.

    SLC28 genes and concentrative nucleoside transporter (CNT) proteins.

    Xenobiotica . 38(7-8): 972-994. Nº de cites: 67

    [doi:10.1080/00498250802069096]

  • Molina-Arcas M, Trigueros-Motos L, Casado FJ and Pastor-Anglada M.

    Physiological and pharmacological roles of nucleoside transporter proteins.

    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS . 27(6): 769-778. Nº de cites: 36

    [doi:10.1080/15257770802145819]

  • Hubeek I, Giovannetti E, Broekhuizen AJ, Pastor-Anglada M, Kaspers GJ and Peters GJ.

    Immunocytochemical detection of hENT1 and hCNT1 in normal tissues, lung cancer cell lines, and NSCLC patient samples.

    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS . 27(6): 787-793. Nº de cites: 7

    [doi:10.1080/15257770802145942]

  • Puebla C, Farías M, González M, Vecchiola A, Aguayo C, Krause B, Pastor-Anglada M, Casanello P and Sobrevia L.

    High D-glucose reduces SLC29A1 promoter activity and adenosine transport involving specific protein 1 in human umbilical vein endothelium.

    J CELL PHYSIOL . 215(3): 645-656. Nº de cites: 25

    [doi:10.1002/jcp.21347]

  • Errasti-Murugarren E, Cano-Soldado P, Pastor-Anglada M and Casado FJ.

    Functional characterization of a nucleoside-derived drug transporter variant (hCNT3C602R) showing altered sodium-binding capacity.

    MOLECULAR PHARMACOLOGY . 73(2): 379-386. Nº de cites: 28

    [doi:10.1124/mol.107.041848]

  • Minuesa G, Purcet S, Erkizia I, Molina-Arcas M, Bofill M, Izquierdo-Useros N, Casado FJ, Clotet B, Pastor-Anglada M and Martinez-Picado J.

    Expression and functionality of anti-human immunodeficiency virus and anticancer drug uptake transporters in immune cells.

    J PHARMACOL EXP THER . 324(2): 558-567. Nº de cites: 55

    [doi:10.1124/jpet.107.131482]

  • Cano-Soldado P, Molina-Arcas M, Algueró B, Larráyoz I, Lostao MP, Grandas A, Casado FJ and Pastor-Anglada M.

    Compensatory effects of the human nucleoside transporters on the response to nucleoside-derived drugs in breast cancer MCF7 cells.

    BIOCHEMICAL PHARMACOLOGY . 75(3): 639-648. Nº de cites: 24

    [doi:10.1016/j.bcp.2007.10.005]

  • Govindarajan R, Bakken AH, Hudkins KL, Lai Y, Casado FJ, Pastor-Anglada M, Tse CM, Hayashi J and Unadkat JD.

    In situ hybridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and placenta.

    AM J PHYSIOL-REG I . 293(5): . Nº de cites: 122

    [doi:10.1152/ajpregu.00293.2007]